You have 9 free searches left this month | for more free features.

Biliary tract cancer

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pancreas Cancer Trial (mRNA expression)

Not yet recruiting
  • Pancreas Cancer
  • mRNA expression
  • (no location specified)
Aug 8, 2022

Platinum-Sensitive Biliary Tract Cancer Trial (Cisplatin, Gemcitabine, Oxaliplatin)

Withdrawn
  • Platinum-Sensitive Biliary Tract Cancer
  • (no location specified)
May 27, 2022

Biliary Tract Cancer Trial in Montréal (Tumour and germline molecular profiling)

Recruiting
  • Biliary Tract Cancer
  • Tumour and germline molecular profiling
  • Montréal, Quebec, Canada
    McGill University Health Centre
Nov 2, 2022

Advanced Biliary Tract Cancer Trial in Guangzhou (Envofolimab, Lenvatinib, Gemcitabine)

Recruiting
  • Advanced Biliary Tract Cancer
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Sun Yat-sen University
Oct 11, 2022

Biliary Tract Cancer, Cholangiocarcinoma Trial in Aachen, Frankfurt (Bintrafusp alfa)

Terminated
  • Biliary Tract Cancer
  • Cholangiocarcinoma
  • Bintrafusp alfa
  • Aachen, Germany
  • +1 more
May 17, 2022

Biliary Tract Cancer Trial in Goyang-si, Seoul (SMT-NK inj.+Pembrolizumab, Pembrolizumab)

Recruiting
  • Biliary Tract Cancer
  • Goyang-si, Gyeonggi-do, Korea, Republic of
  • +2 more
Jun 28, 2022

Metastatic Biliary Tract Cancer Trial in Seoul (Onivyde, 5-FU/LV)

Completed
  • Metastatic Biliary Tract Cancer
  • Seoul, Korea, Republic of
    Asan Medical Center
Aug 22, 2022

European Training Program for Robotic Liver Surgery (LIVEROBOT)

Not yet recruiting
  • Liver Diseases
  • +6 more
  • European Multicentre Training Program for Robotic Liver Surgery
  • (no location specified)
Feb 8, 2023

Biliary Tract Cancer Trial in United States (Nivolumab, Nanoliposomal-Irinotecan, 5-Fluorouracil)

Active, not recruiting
  • Biliary Tract Cancer
  • Ann Arbor, Michigan
  • +4 more
Oct 6, 2022

Biliary Carcinoma Trial in Nanjing (Disitamab Vedotin combined with Zimberelizumab)

Recruiting
  • Biliary Carcinoma
  • Disitamab Vedotin combined with Zimberelizumab
  • Nanjing, Jiangsu, China
    Jiangsu Province Hospital
Sep 14, 2022

Gastrointestinal Cancer Trial in Hangzhou (Pemigatinib Pill)

Recruiting
  • Gastrointestinal Cancer
  • Pemigatinib Pill
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Sep 26, 2022

Biliary Tract Cancer (CCA), Intrahepatic Cholangiocarcinoma, Hilar Cholangiocarcinoma Trial in Frankfurt am Main (Durvalumab,

Recruiting
  • Biliary Tract Cancer (CCA)
  • +4 more
  • Frankfurt am Main, Germany
    Krankenhaus Nordwest
Jun 23, 2022

Advanced Biliary Tract Cancer Trial in Taipei (Lenvatinib Pill,Paclitaxel)

Recruiting
  • Advanced Biliary Tract Cancer
  • Lenvatinib Pill,Paclitaxel
  • Taipei, Taiwan
    Taiwan Cooperative Oncology Group, National Health Research Inst
Jul 27, 2022

Biliary Tract Cancer Trial in Seoul (Pemetrexed 500 MG, Erlotinib)

Recruiting
  • Biliary Tract Cancer
  • Seoul, Korea, Republic of
  • +1 more
Jun 13, 2022

Biliary Tract Cancer, Cholangiocarcinoma, Biliary Tract Tumors Trial in Pittsburgh (Tumor Infiltrating Lymphocytes (TIL))

Recruiting
  • Biliary Tract Cancer
  • +2 more
  • Tumor Infiltrating Lymphocytes (TIL)
  • Pittsburgh, Pennsylvania
    Allyson Welsch
Jul 21, 2022

Biliary Tract Cancer, DNA Damage Repair Deficiency Trial in Seoul (Durvalumab, Olaparib)

Recruiting
  • Biliary Tract Cancer
  • DNA Damage Repair Deficiency
  • Seoul, Korea, Republic of
    Asan Medical Center
Apr 8, 2022

Biliary Tract Cancer Trial in Changchun (Lenvatinib, PD-1 inhibitors)

Recruiting
  • Biliary Tract Cancer
  • Changchun, Jilin, China
    Liu Bo
Aug 18, 2022

Pancreatic Cancer, Hepatocellular Cancer, Biliary Tract Cancer Trial in Edmonton (Durvalumab, Gemcitabine, Nab paclitaxel)

Not yet recruiting
  • Pancreatic Cancer
  • +3 more
  • Durvalumab
  • +5 more
  • Edmonton, Alberta, Canada
    Cross Cancer Institute
Feb 1, 2023

Biliary Tract Cancer, Metastatic Cancer, Advanced Cancer Trial in Germany, Spain, United Kingdom (Pembrolizumab, Cisplatin,

Active, not recruiting
  • Biliary Tract Cancer
  • +3 more
  • Leipzig, Germany
  • +6 more
Jul 1, 2022

Pancreatic Tumors, Solid Tumors, Biliary Tract Cancer Trial (BI 907828)

Not yet recruiting
  • Pancreatic Neoplasms
  • +2 more
  • BI 907828
  • (no location specified)
Aug 22, 2022

Incidental Gallbladder Carcinoma-Permanent Platform Including

Recruiting
  • Biliary Tract Cancer
  • Neoadjuvant, Adjuvant and 1st Line
    • Frankfurt, Germany
      Krankenhaus Nordwest GmbH
    Aug 3, 2022

    Biliary Tract Cancer, Cholangiocarcinoma, Gall Bladder Cancer Trial (CTX-009, Paclitaxel)

    Not yet recruiting
    • Biliary Tract Cancer
    • +3 more
    • (no location specified)
    Aug 16, 2022

    Metastatic Pancreatic Cancer, Metastatic Biliary Tract Cancer Trial in Herlev (Nivolumab, Ipilimumab, Radiotherapy)

    Active, not recruiting
    • Metastatic Pancreatic Cancer
    • Metastatic Biliary Tract Cancer
    • Herlev, Denmark
      Herlev & Gentofte Hospital
    Mar 29, 2022

    Pancreatic Cancer, Biliary Tract Cancer Trial in Oslo, Stockholm (Physical exercise)

    Recruiting
    • Pancreatic Cancer
    • Biliary Tract Cancer
    • Physical exercise
    • Oslo, Norway
    • +1 more
    Mar 30, 2022

    Biliary Tract Diseases, Gallbladder Cancer, Extrahepatic Bile Duct Cancer Trial (no interventions)

    Not yet recruiting
    • Biliary Tract Diseases
    • +5 more
    • no interventions
    • (no location specified)
    Jun 1, 2023